These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 33664322)

  • 41. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression Profile of EMT-related Genes and miRNAs Involved in Signal Transduction via the Wnt Pathway and Cadherins in Endometrial Cancer.
    Zmarzły N; Hermyt E; Kruszniewska-Rajs C; Gola J; Witek A; Mazurek U; Ostenda A; Boroń D
    Curr Pharm Biotechnol; 2021; 22(12):1663-1671. PubMed ID: 33342410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
    Mohammadi-Yeganeh S; Hosseini V; Paryan M
    J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
    Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO
    Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of dysregulated microRNAs in triple-negative breast cancer (review).
    Yang F; Zhang W; Shen Y; Guan X
    Int J Oncol; 2015 Mar; 46(3):927-32. PubMed ID: 25571912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-124-3p.1 promotes cell proliferation through Axin1-dependent Wnt signaling pathway and predicts a poor prognosis of triple-negative breast cancer.
    Yang W; Cui G; Ding M; Yang M; Dai D
    J Clin Lab Anal; 2020 Jul; 34(7):e23266. PubMed ID: 32125723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers.
    Gasparini P; Cascione L; Fassan M; Lovat F; Guler G; Balci S; Irkkan C; Morrison C; Croce CM; Shapiro CL; Huebner K
    Oncotarget; 2014 Mar; 5(5):1174-84. PubMed ID: 24632568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.
    Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F
    Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miRNA-135b Contributes to
    Uva P; Cossu-Rocca P; Loi F; Pira G; Murgia L; Orrù S; Floris M; Muroni MR; Sanges F; Carru C; Angius A; De Miglio MR
    Int J Med Sci; 2018; 15(6):536-548. PubMed ID: 29725243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospectives of mirna gene signaling pathway in triple-negative breast cancer.
    Chakkaravarthi K; Ramesh R; Palaniyandi T; Baskar G; Viswanathan S; Wahab MRA; Surendran H; Ravi M; Sivaji A
    Pathol Res Pract; 2023 Aug; 248():154658. PubMed ID: 37421840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
    Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
    Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
    Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y
    BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of mRNA and non-coding RNA hubs using network analysis in organ tropism regulated triple negative breast cancer metastasis.
    Banerjee S; Kalyani Yabalooru SR; Karunagaran D
    Comput Biol Med; 2020 Dec; 127():104076. PubMed ID: 33126129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miRNA profiling of human nasopharyngeal carcinoma cell lines HONE1 and CNE2 after X-ray therapy.
    Luo H; Zhong F; Jing X; Lin H; Li Y
    Adv Clin Exp Med; 2022 Jun; 31(6):671-687. PubMed ID: 35275451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
    Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
    Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential expression of basal microRNAs' patterns in human dental pulp stem cells.
    Vasanthan P; Govindasamy V; Gnanasegaran N; Kunasekaran W; Musa S; Abu Kasim NH
    J Cell Mol Med; 2015 Mar; 19(3):566-80. PubMed ID: 25475098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition.
    Das K; Paul S; Singh A; Ghosh A; Roy A; Ansari SA; Prasad R; Mukherjee A; Sen P
    J Biol Chem; 2019 Sep; 294(37):13681-13696. PubMed ID: 31341019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A panel of eight microRNAs is a good predictive parameter for triple-negative breast cancer relapse.
    Hong HC; Chuang CH; Huang WC; Weng SL; Chen CH; Chang KH; Liao KW; Huang HD
    Theranostics; 2020; 10(19):8771-8789. PubMed ID: 32754277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.